MRC Confidence in Concept scheme – Flexible institutional awards for preliminary translational work

The Confidence in Concept scheme provides annual awards of £250k-£1.2m to institutions, to be used flexibly to support the earliest stages of multiple translational research projects. It is intended to accelerate the transition from discovery research to translational development projects by supporting preliminary work or feasibility studies to establish the viability of an approach.

The Confidence in Concept Scheme is part of our translational research strategy and is a component of the MRC/Innovate UK Biomedical Catalyst.

Ensuring that fundamental science is translated into new therapies, diagnostics and medical devices is central to our mission. The Confidence in Concept scheme aims to accelerate the transition from discovery science to the early stages of therapeutic/biomarker development by providing locally-administered, responsive and flexible funding to support preliminary translational work.

The award can be used flexibly by the institution to support a number of preliminary-stage translational projects. The projects supported should aim to provide sufficient preliminary data to establish the viability of an approach –– before seeking more substantive funding (e.g. from the Developmental Pathway Funding Scheme (DPFS).

Launch date 7 March 2019

Deadline for expression of interest 10 May 2019

Deadline for full proposal submission 5pm 23 May 2019

Joint panel meeting 18 June 2019